Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders.
Myosin Therapeutics has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in March 2026.
Myosin Therapeutics's investors include DeepWork Capital, National Institutes of Health, UK Innovation & Science Seed Fund, Mayo Clinic Ventures, Florida Opportunity Fund.
Myosin Therapeutics is headquartered in Jupiter, United States.
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders.
Myosin Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Myosin Therapeutics — Funding & Investors." VCBacked, March 23, 2026, https://www.vcbacked.co/company/myosin-therapeutics. Accessed July 19, 2026.
VCBacked. (2026). Myosin Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/myosin-therapeutics
{{cite web |title=Myosin Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/myosin-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated